Mobile Menu

Genomics week in brief: Week ending 13th November

Catch up with some of the latest genomics news and research from the past week in this week’s Genomics Week in Brief.

Top stories from the past week

  • A large study has found a protein in the blood that could predict type II diabetes up to nineteen years before the onset of the disease. (Wu et al, 2021)
  • Neuroscientists have revealed how air pollution and genes multiply people’s risk of depression. (Li et al, 2021)
  • A new study has described the experiences of investigators who disclosed actionable genetic results to participants enrolled in the Mass General Brigham Biobank. (Zawatsky et al, 2021)
  • By harnessing CRISPR/Cas9 genome editing technology, researchers have described a new technique that can be used to explore novel ways of treating diseases associated with dysregulation in DNA methylation. (Sapozhnikov and Szyf, 2021)
  • New research has helped to explain the genetic basis for why we look the way we do. (Auradkar et al, 2021)
  • A comprehensive study has shown that gene editing with CRISPR-Cas9 can favour cells with cancer-linked mutations. (Sinha et al, 2021)
  • Researchers have discovered a novel genetic link to non-alcoholic inflammatory liver disease. (Kulathunga et al, 2021)
  • A recent study in mice has revealed the precise molecular targets of transplant rejection. (Son et al, 2021)
  • A new study has revealed why mutations in the UTX gene disrupt cells’ ability to suppress tumours. (Shi et al, 2021)
  • Researchers have found that regular blood tests can predict which prostate cancer patients are resistant to the chemotherapy drug docetaxel. (Davies, 2021)
  • A new study, using deep-learning in protein-protein interactions, has identified complexes that will advance our understanding of cellular processes. (Humphreys et al, 2021)
  • A recent CRISPR screen has identified a metabolic enzyme as a new anti-inflammatory drug target. (Sugiura et al, 2021)

In other news

  • The University of Colorado School of Medicine researchers have been awarded a $1.6 million grant by the National Eye Institute of the NIH to study systemic biomarkers of inflammation that signal the progression of age-related macular degeneration. (CU Anschutz, 2021)

Image credit: canva


More on these topics

Cancer / Genetic Variants / Genomics / Week in brief

Share this article